Toll Free: 1-888-928-9744

United States Pulmonary Hypertension Drug Industry 2018 Market Research Report

Published: Jan, 2018 | Pages: 98 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

In this report, the United States Pulmonary Hypertension Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Pulmonary Hypertension Drug in these regions, from 2013 to 2025 (forecast).

United States Pulmonary Hypertension Drug market competition by top manufacturers/players, with Pulmonary Hypertension Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Sanofi
    Vectura Group plc
    Bayer AG
    Ikaria Inc.
    Proreo Pharma AG
    Vicore Pharma AB
    Biolab Sanus Farmaceutica Ltda.
    Hanmi Pharmaceuticals, Co. Ltd.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    IK-3001
    Sildenafil Citrate IMD
    IK-7002
    Riociguat
    SAR-407899
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Clinic
    Hospital
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

United States Pulmonary Hypertension Drug Market Report 2018
1 Pulmonary Hypertension Drug Overview
    1.1 Product Overview and Scope of Pulmonary Hypertension Drug
    1.2 Classification of Pulmonary Hypertension Drug by Product Category
        1.2.1 United States Pulmonary Hypertension Drug Market Size (Sales Volume) Comparison by Type (2013-2025)
        1.2.2 United States Pulmonary Hypertension Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
        1.2.3 IK-3001
        1.2.4 Sildenafil Citrate IMD
        1.2.5 IK-7002
        1.2.6 Riociguat
        1.2.7 SAR-407899
        1.2.8 Others
    1.3 United States Pulmonary Hypertension Drug Market by Application/End Users
        1.3.1 United States Pulmonary Hypertension Drug Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 Others
    1.4 United States Pulmonary Hypertension Drug Market by Region
        1.4.1 United States Pulmonary Hypertension Drug Market Size (Value) Comparison by Region (2013-2025)
        1.4.2 The West Pulmonary Hypertension Drug Status and Prospect (2013-2025)
        1.4.3 Southwest Pulmonary Hypertension Drug Status and Prospect (2013-2025)
        1.4.4 The Middle Atlantic Pulmonary Hypertension Drug Status and Prospect (2013-2025)
        1.4.5 New England Pulmonary Hypertension Drug Status and Prospect (2013-2025)
        1.4.6 The South Pulmonary Hypertension Drug Status and Prospect (2013-2025)
        1.4.7 The Midwest Pulmonary Hypertension Drug Status and Prospect (2013-2025)
    1.5 United States Market Size (Value and Volume) of Pulmonary Hypertension Drug (2013-2025)
        1.5.1 United States Pulmonary Hypertension Drug Sales and Growth Rate (2013-2025)
        1.5.2 United States Pulmonary Hypertension Drug Revenue and Growth Rate (2013-2025)

2 United States Pulmonary Hypertension Drug Market Competition by Players/Suppliers
    2.1 United States Pulmonary Hypertension Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
    2.2 United States Pulmonary Hypertension Drug Revenue and Share by Players/Suppliers (2013-2018)
    2.3 United States Pulmonary Hypertension Drug Average Price by Players/Suppliers (2013-2018)
    2.4 United States Pulmonary Hypertension Drug Market Competitive Situation and Trends
        2.4.1 United States Pulmonary Hypertension Drug Market Concentration Rate
        2.4.2 United States Pulmonary Hypertension Drug Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Pulmonary Hypertension Drug Manufacturing Base Distribution, Sales Area, Product Type

3 United States Pulmonary Hypertension Drug Sales (Volume) and Revenue (Value) by Region (2013-2018)
    3.1 United States Pulmonary Hypertension Drug Sales and Market Share by Region (2013-2018)
    3.2 United States Pulmonary Hypertension Drug Revenue and Market Share by Region (2013-2018)
    3.3 United States Pulmonary Hypertension Drug Price by Region (2013-2018)

4 United States Pulmonary Hypertension Drug Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
    4.1 United States Pulmonary Hypertension Drug Sales and Market Share by Type (Product Category) (2013-2018)
    4.2 United States Pulmonary Hypertension Drug Revenue and Market Share by Type (2013-2018)
    4.3 United States Pulmonary Hypertension Drug Price by Type (2013-2018)
    4.4 United States Pulmonary Hypertension Drug Sales Growth Rate by Type (2013-2018)

5 United States Pulmonary Hypertension Drug Sales (Volume) by Application (2013-2018)
    5.1 United States Pulmonary Hypertension Drug Sales and Market Share by Application (2013-2018)
    5.2 United States Pulmonary Hypertension Drug Sales Growth Rate by Application (2013-2018)
    5.3 Market Drivers and Opportunities

6  United States Pulmonary Hypertension Drug Players/Suppliers Profiles and Sales Data
    6.1 Sanofi
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Pulmonary Hypertension Drug Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Sanofi Pulmonary Hypertension Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        6.1.4 Main Business/Business Overview
    6.2 Vectura Group plc
        6.2.2 Pulmonary Hypertension Drug Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Vectura Group plc Pulmonary Hypertension Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        6.2.4 Main Business/Business Overview
    6.3 Bayer AG
        6.3.2 Pulmonary Hypertension Drug Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Bayer AG Pulmonary Hypertension Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        6.3.4 Main Business/Business Overview
    6.4 Ikaria Inc.
        6.4.2 Pulmonary Hypertension Drug Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Ikaria Inc. Pulmonary Hypertension Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        6.4.4 Main Business/Business Overview
    6.5 Proreo Pharma AG
        6.5.2 Pulmonary Hypertension Drug Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Proreo Pharma AG Pulmonary Hypertension Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        6.5.4 Main Business/Business Overview
    6.6 Vicore Pharma AB
        6.6.2 Pulmonary Hypertension Drug Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Vicore Pharma AB Pulmonary Hypertension Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        6.6.4 Main Business/Business Overview
    6.7 Biolab Sanus Farmaceutica Ltda.
        6.7.2 Pulmonary Hypertension Drug Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Biolab Sanus Farmaceutica Ltda. Pulmonary Hypertension Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        6.7.4 Main Business/Business Overview
    6.8 Hanmi Pharmaceuticals, Co. Ltd.
        6.8.2 Pulmonary Hypertension Drug Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Hanmi Pharmaceuticals, Co. Ltd. Pulmonary Hypertension Drug Sales, Revenue, Price and Gross Margin (2013-2018)
        6.8.4 Main Business/Business Overview

7 Pulmonary Hypertension Drug Manufacturing Cost Analysis
    7.1 Pulmonary Hypertension Drug Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Pulmonary Hypertension Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Pulmonary Hypertension Drug Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Pulmonary Hypertension Drug Major Manufacturers in 2017
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Pulmonary Hypertension Drug Market Size (Value and Volume) Forecast (2018-2025)
    11.1 United States Pulmonary Hypertension Drug Sales Volume, Revenue Forecast (2018-2025)
    11.2 United States Pulmonary Hypertension Drug Sales Volume Forecast by Type (2018-2025)
    11.3 United States Pulmonary Hypertension Drug Sales Volume Forecast by Application (2018-2025)
    11.4 United States Pulmonary Hypertension Drug Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer


List of Tables and Figures

    Figure Product Picture of Pulmonary Hypertension Drug
    Figure United States Pulmonary Hypertension Drug Market Size (K Pcs) by Type (2013-2025)
    Figure United States Pulmonary Hypertension Drug Sales Volume Market Share by Type (Product Category) in 2017
    Figure IK-3001 Product Picture
    Figure Sildenafil Citrate IMD Product Picture
    Figure IK-7002 Product Picture
    Figure Riociguat Product Picture
    Figure SAR-407899 Product Picture
    Figure Others Product Picture
    Figure United States Pulmonary Hypertension Drug Market Size (K Pcs) by Application (2013-2025)
    Figure United States Sales Market Share of Pulmonary Hypertension Drug by Application in 2017
    Figure Clinic Examples
    Table Key Downstream Customer in Clinic
    Figure Hospital Examples
    Table Key Downstream Customer in Hospital
    Figure Others Examples
    Table Key Downstream Customer in Others
    Figure United States Pulmonary Hypertension Drug Market Size (Million USD) by Region (2013-2025)
    Figure The West Pulmonary Hypertension Drug Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Southwest Pulmonary Hypertension Drug Revenue (Million USD) and Growth Rate (2013-2025)
    Figure The Middle Atlantic Pulmonary Hypertension Drug Revenue (Million USD) and Growth Rate (2013-2025)
    Figure New England Pulmonary Hypertension Drug Revenue (Million USD) and Growth Rate (2013-2025)
    Figure The South of US Pulmonary Hypertension Drug Revenue (Million USD) and Growth Rate (2013-2025)
    Figure The Midwest Pulmonary Hypertension Drug Revenue (Million USD) and Growth Rate (2013-2025)
    Figure United States Pulmonary Hypertension Drug Sales (K Pcs) and Growth Rate (2013-2025)
    Figure United States Pulmonary Hypertension Drug Revenue (Million USD) and Growth Rate (2013-2025)
    Figure United States Pulmonary Hypertension Drug Market Major Players Product Sales Volume (K Pcs) (2013-2018)
    Table United States Pulmonary Hypertension Drug Sales (K Pcs) of Key Players/Suppliers (2013-2018)
    Table United States Pulmonary Hypertension Drug Sales Share by Players/Suppliers (2013-2018)
    Figure 2017 United States Pulmonary Hypertension Drug Sales Share by Players/Suppliers
    Figure 2017 United States Pulmonary Hypertension Drug Sales Share by Players/Suppliers
    Figure United States Pulmonary Hypertension Drug Market Major Players Product Revenue (Million USD) (2013-2018)
    Table United States Pulmonary Hypertension Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
    Table United States Pulmonary Hypertension Drug Revenue Share by Players/Suppliers (2013-2018)
    Figure 2017 United States Pulmonary Hypertension Drug Revenue Share by Players/Suppliers
    Figure 2017 United States Pulmonary Hypertension Drug Revenue Share by Players/Suppliers
    Table United States Market Pulmonary Hypertension Drug Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
    Figure United States Market Pulmonary Hypertension Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2017
    Figure United States Pulmonary Hypertension Drug Market Share of Top 3 Players/Suppliers
    Figure United States Pulmonary Hypertension Drug Market Share of Top 5 Players/Suppliers
    Table United States Players/Suppliers Pulmonary Hypertension Drug Manufacturing Base Distribution and Sales Area
    Table United States Players/Suppliers Pulmonary Hypertension Drug Product Category
    Table United States Pulmonary Hypertension Drug Sales (K Pcs) by Region (2013-2018)
    Table United States Pulmonary Hypertension Drug Sales Share by Region (2013-2018)
    Figure United States Pulmonary Hypertension Drug Sales Share by Region (2013-2018)
    Figure United States Pulmonary Hypertension Drug Sales Market Share by Region in 2017
    Table United States Pulmonary Hypertension Drug Revenue (Million USD) and Market Share by Region (2013-2018)
    Table United States Pulmonary Hypertension Drug Revenue Share by Region (2013-2018)
    Figure United States Pulmonary Hypertension Drug Revenue Market Share by Region (2013-2018)
    Figure United States Pulmonary Hypertension Drug Revenue Market Share by Region in 2017
    Table United States Pulmonary Hypertension Drug Price (USD/Pcs) by Region (2013-2018)
    Table United States Pulmonary Hypertension Drug Sales (K Pcs) by Type (2013-2018)
    Table United States Pulmonary Hypertension Drug Sales Share by Type (2013-2018)
    Figure United States Pulmonary Hypertension Drug Sales Share by Type (2013-2018)
    Figure United States Pulmonary Hypertension Drug Sales Market Share by Type in 2017
    Table United States Pulmonary Hypertension Drug Revenue  (Million USD) and Market Share by Type (2013-2018)
    Table United States Pulmonary Hypertension Drug Revenue Share by Type (2013-2018)
    Figure Revenue Market Share of Pulmonary Hypertension Drug by Type (2013-2018)
    Figure Revenue Market Share of Pulmonary Hypertension Drug by Type in 2017
    Table United States Pulmonary Hypertension Drug Price (USD/Pcs) by Types (2013-2018)
    Figure United States Pulmonary Hypertension Drug Sales Growth Rate by Type (2013-2018)
    Table United States Pulmonary Hypertension Drug Sales (K Pcs) by Application (2013-2018)
    Table United States Pulmonary Hypertension Drug Sales Market Share by Application (2013-2018)
    Figure United States Pulmonary Hypertension Drug Sales Market Share by Application (2013-2018)
    Figure United States Pulmonary Hypertension Drug Sales Market Share by Application in 2017
    Table United States Pulmonary Hypertension Drug Sales Growth Rate by Application (2013-2018)
    Figure United States Pulmonary Hypertension Drug Sales Growth Rate by Application (2013-2018)
    Table Sanofi Basic Information List
    Table Sanofi Pulmonary Hypertension Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Sanofi Pulmonary Hypertension Drug Sales Growth Rate (2013-2018)
    Figure Sanofi Pulmonary Hypertension Drug Sales Market Share in United States (2013-2018)
    Figure Sanofi Pulmonary Hypertension Drug Revenue Market Share in United States (2013-2018)
    Table Vectura Group plc Basic Information List
    Table Vectura Group plc Pulmonary Hypertension Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Vectura Group plc Pulmonary Hypertension Drug Sales Growth Rate (2013-2018)
    Figure Vectura Group plc Pulmonary Hypertension Drug Sales Market Share in United States (2013-2018)
    Figure Vectura Group plc Pulmonary Hypertension Drug Revenue Market Share in United States (2013-2018)
    Table Bayer AG Basic Information List
    Table Bayer AG Pulmonary Hypertension Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Bayer AG Pulmonary Hypertension Drug Sales Growth Rate (2013-2018)
    Figure Bayer AG Pulmonary Hypertension Drug Sales Market Share in United States (2013-2018)
    Figure Bayer AG Pulmonary Hypertension Drug Revenue Market Share in United States (2013-2018)
    Table Ikaria Inc. Basic Information List
    Table Ikaria Inc. Pulmonary Hypertension Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Ikaria Inc. Pulmonary Hypertension Drug Sales Growth Rate (2013-2018)
    Figure Ikaria Inc. Pulmonary Hypertension Drug Sales Market Share in United States (2013-2018)
    Figure Ikaria Inc. Pulmonary Hypertension Drug Revenue Market Share in United States (2013-2018)
    Table Proreo Pharma AG Basic Information List
    Table Proreo Pharma AG Pulmonary Hypertension Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Proreo Pharma AG Pulmonary Hypertension Drug Sales Growth Rate (2013-2018)
    Figure Proreo Pharma AG Pulmonary Hypertension Drug Sales Market Share in United States (2013-2018)
    Figure Proreo Pharma AG Pulmonary Hypertension Drug Revenue Market Share in United States (2013-2018)
    Table Vicore Pharma AB Basic Information List
    Table Vicore Pharma AB Pulmonary Hypertension Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Vicore Pharma AB Pulmonary Hypertension Drug Sales Growth Rate (2013-2018)
    Figure Vicore Pharma AB Pulmonary Hypertension Drug Sales Market Share in United States (2013-2018)
    Figure Vicore Pharma AB Pulmonary Hypertension Drug Revenue Market Share in United States (2013-2018)
    Table Biolab Sanus Farmaceutica Ltda. Basic Information List
    Table Biolab Sanus Farmaceutica Ltda. Pulmonary Hypertension Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Biolab Sanus Farmaceutica Ltda. Pulmonary Hypertension Drug Sales Growth Rate (2013-2018)
    Figure Biolab Sanus Farmaceutica Ltda. Pulmonary Hypertension Drug Sales Market Share in United States (2013-2018)
    Figure Biolab Sanus Farmaceutica Ltda. Pulmonary Hypertension Drug Revenue Market Share in United States (2013-2018)
    Table Hanmi Pharmaceuticals, Co. Ltd. Basic Information List
    Table Hanmi Pharmaceuticals, Co. Ltd. Pulmonary Hypertension Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Hanmi Pharmaceuticals, Co. Ltd. Pulmonary Hypertension Drug Sales Growth Rate (2013-2018)
    Figure Hanmi Pharmaceuticals, Co. Ltd. Pulmonary Hypertension Drug Sales Market Share in United States (2013-2018)
    Figure Hanmi Pharmaceuticals, Co. Ltd. Pulmonary Hypertension Drug Revenue Market Share in United States (2013-2018)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Pulmonary Hypertension Drug
    Figure Manufacturing Process Analysis of Pulmonary Hypertension Drug
    Figure Pulmonary Hypertension Drug Industrial Chain Analysis
    Table Raw Materials Sources of Pulmonary Hypertension Drug Major Players/Suppliers in 2017
    Table Major Buyers of Pulmonary Hypertension Drug
    Table Distributors/Traders List
    Figure United States Pulmonary Hypertension Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
    Figure United States Pulmonary Hypertension Drug Revenue  (Million USD) and Growth Rate Forecast (2018-2025)
    Figure United States Pulmonary Hypertension Drug Price (USD/Pcs) Trend Forecast (2018-2025)
    Table United States Pulmonary Hypertension Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
    Figure United States Pulmonary Hypertension Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
    Figure United States Pulmonary Hypertension Drug Sales Volume (K Pcs) Forecast by Type in 2025
    Table United States Pulmonary Hypertension Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
    Figure United States Pulmonary Hypertension Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
    Figure United States Pulmonary Hypertension Drug Sales Volume (K Pcs) Forecast by Application in 2025
    Table United States Pulmonary Hypertension Drug Sales Volume (K Pcs) Forecast by Region (2018-2025)
    Table United States Pulmonary Hypertension Drug Sales Volume Share Forecast by Region (2018-2025)
    Figure United States Pulmonary Hypertension Drug Sales Volume Share Forecast by Region (2018-2025)
    Figure United States Pulmonary Hypertension Drug Sales Volume Share Forecast by Region in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
 



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $3800
Multi User - US $7600
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify